294 related articles for article (PubMed ID: 32039859)
1. RESTORE: A Prospective Multinational Registry of Patients with Genetically Confirmed Spinal Muscular Atrophy - Rationale and Study Design.
Finkel RS; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Shieh PB; Tizzano E; Desguerre I; Quijano-Roy S; Saito K; Droege M; Dabbous O; Khan F; Renault L; Anderson FA; Servais L
J Neuromuscul Dis; 2020; 7(2):145-152. PubMed ID: 32039859
[TBL] [Abstract][Full Text] [Related]
2. Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry.
Servais L; Day JW; De Vivo DC; Kirschner J; Mercuri E; Muntoni F; Proud CM; Shieh PB; Tizzano EF; Quijano-Roy S; Desguerre I; Saito K; Faulkner E; Benguerba KM; Raju D; LaMarca N; Sun R; Anderson FA; Finkel RS
J Neuromuscul Dis; 2024; 11(2):425-442. PubMed ID: 38250783
[TBL] [Abstract][Full Text] [Related]
3. The Japan Registry for Adult Subjects of Spinal Muscular Atrophy (jREACT-SMA): Protocol for a Longitudinal Observational Study.
Sahashi K; Hashizume A; Kuwatsuka Y; Chinen M; Saotome-Nakamura A; Ando M; Katsuno M
JMIR Res Protoc; 2022 Dec; 11(12):e38878. PubMed ID: 36520510
[TBL] [Abstract][Full Text] [Related]
4. A National Spinal Muscular Atrophy Registry for Real-World Evidence.
Hodgkinson VL; Oskoui M; Lounsberry J; M'Dahoma S; Butler E; Campbell C; MacKenzie A; McMillan HJ; Simard L; Vajsar J; Brais B; Chapman KM; Chrestian N; Crone M; Dobrowolski P; Dojeiji S; Dowling JJ; Dupré N; Genge A; Gonorazky H; Hasal S; Izenberg A; Johnston W; Leung E; Lochmüller H; Mah JK; Marerro A; Massie R; McAdam L; McCormick A; Melanson M; Mezei MM; Nguyen CE; O'Connell C; O'Ferrall EK; Pfeffer G; Phan C; Plamondon S; Poulin C; Rodrigue X; Schellenberg KL; Selby K; Sheriko J; Shoesmith C; Smith G; Taillon M; Taylor S; Warman Chardon J; Worley S; Korngut L
Can J Neurol Sci; 2020 Nov; 47(6):810-815. PubMed ID: 32493524
[TBL] [Abstract][Full Text] [Related]
5. SMArtCARE - A platform to collect real-life outcome data of patients with spinal muscular atrophy.
Pechmann A; König K; Bernert G; Schachtrup K; Schara U; Schorling D; Schwersenz I; Stein S; Tassoni A; Vogt S; Walter MC; Lochmüller H; Kirschner J
Orphanet J Rare Dis; 2019 Jan; 14(1):18. PubMed ID: 30665421
[TBL] [Abstract][Full Text] [Related]
6. RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.
Cattinari MG; de Lemus M; Tizzano E
Orphanet J Rare Dis; 2024 Feb; 19(1):76. PubMed ID: 38373977
[TBL] [Abstract][Full Text] [Related]
7. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study.
Pechmann A; Behrens M; Dörnbrack K; Tassoni A; Wenzel F; Stein S; Vogt S; Zöller D; Bernert G; Hagenacker T; Schara-Schmidt U; Walter MC; Bertsche A; Vill K; Baumann M; Baumgartner M; Cordts I; Eisenkölbl A; Flotats-Bastardas M; Friese J; Günther R; Hahn A; Horber V; Husain RA; Illsinger S; Jahnel J; Johannsen J; Köhler C; Kölbel H; Müller M; von Moers A; Schwerin-Nagel A; Reihle C; Schlachter K; Schreiber G; Schwartz O; Smitka M; Steiner E; Trollmann R; Weiler M; Weiß C; Wiegand G; Wilichowski E; Ziegler A; Lochmüller H; Kirschner J;
Orphanet J Rare Dis; 2022 Oct; 17(1):384. PubMed ID: 36274155
[TBL] [Abstract][Full Text] [Related]
8. [The SMA France national registry: already encouraging results].
Lemoine M; Gomez M; Grimaldi L; Urtizberea JA; Quijano-Roy S
Med Sci (Paris); 2021 Nov; 37 Hors série n° 1():25-29. PubMed ID: 34878390
[TBL] [Abstract][Full Text] [Related]
9. Development of an academic disease registry for spinal muscular atrophy.
Mercuri E; Finkel R; Scoto M; Hall S; Eaton S; Rashid A; Balashkina J; Coratti G; Pera MC; Samsuddin S; Civitello M; Muntoni F;
Neuromuscul Disord; 2019 Oct; 29(10):794-799. PubMed ID: 31558335
[TBL] [Abstract][Full Text] [Related]
10. Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany.
Leibrock B; Landfeldt E; Hussong J; Huelle T; Mattheus H; Thiele S; Walter MC; Zemlin M; Moehler E; Dillman U; Abner S; Flotats-Bastardas M
Orphanet J Rare Dis; 2023 Feb; 18(1):32. PubMed ID: 36810103
[TBL] [Abstract][Full Text] [Related]
11. A multi-source approach to determine SMA incidence and research ready population.
Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
[TBL] [Abstract][Full Text] [Related]
12. Clinical Effectiveness of Newborn Screening for Spinal Muscular Atrophy: A Nonrandomized Controlled Trial.
Schwartz O; Vill K; Pfaffenlehner M; Behrens M; Weiß C; Johannsen J; Friese J; Hahn A; Ziegler A; Illsinger S; Smitka M; von Moers A; Kölbel H; Schreiber G; Kaiser N; Wilichowski E; Flotats-Bastardas M; Husain RA; Baumann M; Köhler C; Trollmann R; Schwerin-Nagel A; Eisenkölbl A; Schimmel M; Fleger M; Kauffmann B; Wiegand G; Baumgartner M; Rauscher C; Cirak S; Gläser D; Bernert G; Hagenacker T; Goldbach S; Probst-Schendzielorz K; Lochmüller H; Müller-Felber W; Schara-Schmidt U; Walter MC; Kirschner J; Pechmann A;
JAMA Pediatr; 2024 Jun; 178(6):540-547. PubMed ID: 38587854
[TBL] [Abstract][Full Text] [Related]
13. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
[TBL] [Abstract][Full Text] [Related]
14. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey.
Belter L; Cruz R; Jarecki J
Orphanet J Rare Dis; 2020 Aug; 15(1):217. PubMed ID: 32838797
[TBL] [Abstract][Full Text] [Related]
15. Caregiver Burden of Spinal Muscular Atrophy: A Systematic Review.
Landfeldt E; Abner S; Pechmann A; Sejersen T; McMillan HJ; Lochmüller H; Kirschner J
Pharmacoeconomics; 2023 Mar; 41(3):275-293. PubMed ID: 36515815
[TBL] [Abstract][Full Text] [Related]
16. Patient and Caregiver Outcomes After Onasemnogene Abeparvovec Treatment: Findings from the Cure SMA 2021 Membership Survey.
Toro W; Yang M; Georgieva M; Anderson A; LaMarca N; Patel A; Akbarnejad H; Dabbous O
Adv Ther; 2023 Dec; 40(12):5315-5337. PubMed ID: 37776479
[TBL] [Abstract][Full Text] [Related]
17. Spinal muscular atrophy: survival pattern and functional status.
Chung BH; Wong VC; Ip P
Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
[TBL] [Abstract][Full Text] [Related]
18. Spinal Muscular Atrophy: Past, Present, and Future.
Ross LF; Kwon JM
Neoreviews; 2019 Aug; 20(8):e437-e451. PubMed ID: 31371553
[TBL] [Abstract][Full Text] [Related]
19. Sex Difference in Spinal Muscular Atrophy Patients - are Males More Vulnerable?
Sun J; Harrington MA; Porter B;
J Neuromuscul Dis; 2023; 10(5):847-867. PubMed ID: 37393514
[TBL] [Abstract][Full Text] [Related]
20. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
